行情

DVA

DVA

达维塔保健
NYSE

实时行情|Nasdaq Last Sale

72.41
+1.37
+1.93%
已收盘, 16:54 11/19 EST
开盘
71.63
昨收
71.04
最高
72.83
最低
71.33
成交量
225.08万
成交额
--
52周最高
72.83
52周最低
43.40
市值
93.92亿
市盈率(TTM)
18.90
分时
5日
1月
3月
1年
5年

分析师评级

12位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

DVA 新闻

  • Barclays Maintains Overweight on DaVita, Raises Price Target to $79
  • Benzinga.20小时前
  • Stocks Little Changed...Except for the New Highs
  • Zacks.23小时前
  • Healthcare And Biotechnology Dashboard - Update
  • Seeking Alpha - Article.1天前
  • Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q3 2019 Update
  • Seeking Alpha - Article.4天前

更多

所属板块

医疗设施与服务
+0.81%
医疗保健提供商与服务
+0.54%

热门股票

名称
价格
涨跌幅

DVA 简况

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.
展开

Webull提供Davita Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。